Segall Bryant & Hamill LLC Grows Position in Ingevity Co. (NYSE:NGVT)

Segall Bryant & Hamill LLC grew its position in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 8.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,287,281 shares of the company's stock after purchasing an additional 101,866 shares during the quarter. Ingevity makes up about 0.7% of Segall Bryant & Hamill LLC's holdings, making the stock its 18th largest position. Segall Bryant & Hamill LLC owned 3.54% of Ingevity worth $52,457,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. State Street Corp raised its position in Ingevity by 14.7% in the 3rd quarter. State Street Corp now owns 1,546,957 shares of the company's stock valued at $60,331,000 after purchasing an additional 198,300 shares during the last quarter. American Century Companies Inc. raised its stake in Ingevity by 37.7% during the 4th quarter. American Century Companies Inc. now owns 1,457,365 shares of the company's stock valued at $59,388,000 after acquiring an additional 398,800 shares during the last quarter. Royce & Associates LP grew its position in Ingevity by 22.4% in the 4th quarter. Royce & Associates LP now owns 1,142,598 shares of the company's stock valued at $46,561,000 after buying an additional 208,921 shares during the last quarter. Geode Capital Management LLC increased its stake in Ingevity by 4.3% in the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company's stock valued at $31,817,000 after buying an additional 33,973 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in Ingevity by 6.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 646,267 shares of the company's stock worth $26,335,000 after buying an additional 38,639 shares during the last quarter. 91.59% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

A number of research analysts have recently issued reports on NGVT shares. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $62.00 to $65.00 in a research note on Wednesday, February 26th. StockNews.com downgraded Ingevity from a "buy" rating to a "hold" rating in a report on Monday, March 24th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $55.17.

Ingevity Price Performance

Shares of NGVT traded down $0.10 during mid-day trading on Friday, reaching $39.62. 273,717 shares of the company's stock were exchanged, compared to its average volume of 267,334. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. Ingevity Co. has a 52-week low of $30.90 and a 52-week high of $56.30. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -3.35 and a beta of 1.53. The company has a 50-day simple moving average of $45.16 and a two-hundred day simple moving average of $42.54.

Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.66. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The company had revenue of $298.80 million for the quarter, compared to analysts' expectations of $297.40 million. On average, sell-side analysts predict that Ingevity Co. will post 4.45 EPS for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.